Forensic drug screening by liquid chromatography hyphenated with high-resolution mass spectrometry (LC-HRMS)

No abstract is available for this paper.

• Publication year

  2023

• Venue

  Trends in Analytical Chemistry (TrAC)

• Publication date

  2023-03-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/j.trac.2023.117023
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• A New Strategy for Efficient Retrospective Data Analyses for Designer Benzodiazepines in Large LC-HRMS Datasets

  2022cited by this paper
• Advances in suspect screening and non-target analysis of polar emerging contaminants in the environmental monitoring

  2022cited by this paper
• Discovery of Tyrosinase Inhibitors: Structure-Based Virtual Screening and Biological Evaluation

  2022cited by this paper
• Developments in high-resolution mass spectrometric analyses of new psychoactive substances

  2022cited by this paper
• Liquid Chromatography High Resolution Mass Spectrometry in Forensic Toxicology: What Are the Specifics of Method Development, Validation and Quality Assurance for Comprehensive Screening Approaches?

  2022cited by this paper
• Retrospective identification of new psychoactive substances in patient samples submitted for clinical drug analysis

  2022cited by this paper
• Metabolomics-driven determination of targets for salicylic acid and ibuprofen in positive electrospray ionization using LC-HRMS.

  2022cited by this paper
• Postmortem Metabolomics Reveal Acylcarnitines as Potential Biomarkers for Fatal Oxycodone-Related Intoxication

  2022cited by this paper
• A deep generative model enables automated structure elucidation of novel psychoactive substances

  2021cited by this paper
• Comprehensive UHPLC-HR-MSE screening workflow optimized for use in routine laboratory medicine: Four workflows in one analytical method.

  2021cited by this paper
• Post-Mortem Metabolomics: A Novel Approach in Clinical Biomarker Discovery and a Potential Tool in Death Investigations.

  2021cited by this paper
• Development of a single retention time prediction model integrating multiple liquid chromatography systems: Application to new psychoactive substances.

  2021cited by this paper
• Online surveillance of novel psychoactive substances (NPS): Monitoring Reddit discussions as a predictor of increased NPS-related exposures.

  2021cited by this paper
• Retrospective screening of synthetic cannabinoids, synthetic opioids and designer benzodiazepines in data files from forensic post mortem samples analysed by UHPLC-QTOF-MS from 2014 to 2018.

  2020cited by this paper
• How to perform spectrum-based LC-HR-MS screening for more than 1,000 NPS with HighResNPS consensus fragment ions

  2020cited by this paper
• Comprehensive Drug Screening of Whole Blood by LC-HRMS-MS in a Forensic Laboratory.

  2020cited by this paper
• Metabolomic Strategies in Biomarker Research–New Approach for Indirect Identification of Drug Consumption and Sample Manipulation in Clinical and Forensic Toxicology?

  2019cited by this paper
• Application of High-Resolution UPLC-MSE/TOF Confirmation in Forensic Urine Drug Screening by UPLC-MS/MS.

  2019cited by this paper
• Identification of phenobarbital and other barbiturates in forensic drug screening using positive electrospray ionization liquid chromatography-high resolution mass spectrometry.

  2019cited by this paper
• HighResNPS.com: An Online Crowd-Sourced HR-MS Database for Suspect and Non-targeted Screening of New Psychoactive Substances.

  2019cited by this paper
• Retrospective analysis for valproate screening targets with liquid chromatography-high resolution mass spectrometry with positive electrospray ionization: An omics-based approach.

  2018cited by this paper
• Validation of a fully automated solid-phase extraction and ultra-high-performance liquid chromatography-tandem mass spectrometry method for quantification of 30 pharmaceuticals and metabolites in post-mortem blood and brain samples.

  2018cited by this paper
• Systematic forensic toxicological analysis by liquid-chromatography-quadrupole-time-of-flight mass spectrometry in serum and comparison to gas chromatography-mass spectrometry.

  2018cited by this paper
• Prediction of collision cross section and retention time for broad scope screening in gradient reversed-phase liquid chromatography-ion mobility-high resolution accurate mass spectrometry.

  2018cited by this paper
• A Validated Method for the Screening of 320 Forensically Significant Compounds in Blood by LC/QTOF, with Simultaneous Quantification of Selected Compounds.

  2018cited by this paper
• Application of a screening method for fentanyl and its analogues using UHPLC-QTOF-MS with data-independent acquisition (DIA) in MSE mode and retrospective analysis of authentic forensic blood samples.

  2018cited by this paper
• A Case Study Involving U-47700, Diclazepam and Flubromazepam-Application of Retrospective Analysis of HRMS Data.

  2018cited by this paper
• Targeted and non-targeted drug screening in whole blood by UHPLC-TOF-MS with data-independent acquisition.

  2017cited by this paper
• Liquid chromatography-quadrupole-time-of-flight mass spectrometry screening procedure for urine samples in forensic casework compared to gas chromatography-mass spectrometry.

  2017cited by this paper
• High-throughput screening for drugs of abuse and pharmaceutical drugs in hair by liquid-chromatography-high resolution mass spectrometry (LC-HRMS)

  2017cited by this paper
• Nontargeted screening of chemical contaminants and illegal additives in food based on liquid chromatography–high resolution mass spectrometry

  2017cited by this paper
• Mass spectral databases for LC/MS- and GC/MS-based metabolomics: state of the field and future prospects

  2016cited by this paper
• A Metabolomics Study of Retrospective Forensic Data from Whole Blood Samples of Humans Exposed to 3,4-Methylenedioxymethamphetamine: A New Approach for Identifying Drug Metabolites and Changes in Metabolism Related to Drug Consumption.

  2016cited by this paper
• Fully automated semi-quantitative toxicological screening in three biological matrices using turbulent flow chromatography/high resolution mass spectrometry.

  2016cited by this paper
• Targeted toxicological screening for acidic, neutral and basic substances in postmortem and antemortem whole blood using simple protein precipitation and UPLC-HR-TOF-MS.

  2016cited by this paper
• Comparison between drug screening by immunoassay and ultra-high performance liquid chromatography/high-resolution time-of-flight mass spectrometry in post-mortem urine.

  2015cited by this paper
• Orbitrap technology for comprehensive metabolite-based liquid chromatographic-high resolution-tandem mass spectrometric urine drug screening - exemplified for cardiovascular drugs.

  2015cited by this paper
• Liquid chromatography high-resolution TOF analysis: investigation of MSE for broad-spectrum drug screening.

  2014cited by this paper
• Direct analysis of the mushroom poisons α- and β-amanitin in human urine using a novel on-line turbulent flow chromatography mode coupled to liquid chromatography-high resolution-mass spectrometry/mass spectrometry.

  2014cited by this paper
• Validation of LC-TOF-MS screening for drugs, metabolites, and collateral compounds in forensic toxicology specimens.

  2013cited by this paper
• Drug screening in medical examiner casework by high-resolution mass spectrometry (UPLC-MSE-TOF).

  2013cited by this paper
• Validation of a fully automated robotic setup for preparation of whole blood samples for LC-MS toxicology analysis.

  2012cited by this paper
• Development and practical application of a library of CID accurate mass spectra of more than 2,500 toxic compounds for systematic toxicological analysis by LC–QTOF-MS with data-dependent acquisition

  2011cited by this paper
• Detection of JWH-018 metabolites in smoking mixture post-administration urine.

  2010cited by this paper

• Organophosphate pesticides in cereal grains: analytical advances, processing, and risk assessment

  2026cites this paper
• Use of nitrogen as an alternative to helium in gas chromatography/mass spectrometry for forensic toxicological analysis.

  2026cites this paper
• Discovery-Based Analysis for Chemical Trends in Chromatographic Data Sets Using Alteration Analysis and Two-Dimensional Correlation Analysis.

  2025cites this paper
• Structure elucidation and quantification of the active pharmaceutical ingredient in a non-approved drug and in cat serum using QTRAP-MS/MS and ZenoTOF-MS/MS.

  2025cites this paper
• Innovative applications of nanotechnology in enhancing forensic science investigations

  2025cites this paper
• Large-scale generation of in silico based spectral libraries to annotate dark chemical space features in non-target analysis

  2025cites this paper
• Recent progress in the application of chemical attribution in forensic profiles

  2024cites this paper
• False-positive MDA findings in HRMS-based screening of putrefied postmortem blood samples-Identification of the interference as N-acetyltyramine.

  2024cites this paper
• Screening for Forensically Relevant Drugs Using Data-Independent High-Resolution Mass Spectrometry

  2024cites this paper
• Validation of two LCHRMS methods for large-scale untargeted metabolomics of serum samples: Strategy to establish method fitness-for-purpose.

  2024cites this paper
• Push forward LC-MS-based therapeutic drug monitoring and pharmacometabolomics for anti-tuberculosis precision dosing and comprehensive clinical management

  2023cites this paper
• Role of postmortem toxicology in drowning investigations

  2023cites this paper